Avalyn Pharma Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 26 | Q2 26 |
|---|---|---|
| – | +213.6% | |
| – | +175.2% | |
| – | +186.2% | |
| – | +186.2% | |
| – | +561.7% | |
| – | -93.2% | |
| – | -8.3% | |
| – | +60.9% | |
| – | -15.9% | |
| – | 0.0% | |
| – | – | |
| – | – | |
| – | +6.0% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.